Morbid Obesity, Laparoscopic Sleeve Gastrectomy, Transversus Abdominis Plane Block, Local Wound Infiltration, Bupivacine, Opioid Use
Conditions
Brief summary
The goal of this randomized controlled trial is to compare laparoscopic guided peri-wound Transversus Abdominis Plane Block and bupivacaine versus local wound infiltration effect on reducing post-op opioid use in Laparoscopic Sleeve gastrectomy. The main questions it aims to answer are: • Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration. Participants will be randomize into 2 group * peri-wound Transversus Abdominis Plane Block * local wound port site infiltration
Interventions
0.25% bupivacaine 20ml was injected using no24 needle into a plane between internal oblique muscle and transversus abdominis muscle around every wound 2 cm. from wound opening. The procedure was confirmed by laparoscopic vision and the injection was done before removal of laparoscopic port.
0.25% bupivacaine 20ml was injected using no24 needle into subcutaneous tissue after the abdominal sheet was sutured.
Sponsors
Study design
Intervention model description
Periwound-TAP block using 0.25%Bupivacain 20ml and local wound infiltration using 0.25%Bupivacain 20ml
Eligibility
Inclusion criteria
* patient undergoing LSG at Sringarind hospital as indicated by Thai guideline
Exclusion criteria
* Allergic/contraindicated to bupivacaine, morphine, fentanyl, NSAIDs or Nefopam * Unable to describe pain score Opioid addict * denied consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative morphine use | 48hours after intervention |
Secondary
| Measure | Time frame |
|---|---|
| Post op VAS pain score | 48hours after intervention |
| length of hospital stay | within admission |
| opioid side effect | within admission |
| PACU time | 1day after intervention |
| postop complication | 2weeks after intervention |
Countries
Thailand